https://www.selleckchem.com/pr....oducts/--mk-801-male
05). Of 127 (97%) participants with at least 1 follow-up HCV VL, 110 (87%) achieved SVR at 12 weeks. Of the total 131 participants, 123 (94%) eventually achieved SVR. Less than half of HIV/HCV coinfected patients in HOPS have been prescribed DAAs. Interventions are needed to address deficits in DAA prescription, including among patients with public or no health insurance, younger age, and lower CD4 cell count.Understanding the implementation process is critical to disseminating effective interventions that reduce HIV risk and i
Like
Comment
Share
